K193519: BioFire Blood Culture Identification 2 (BCID2) Panel (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K193519 (BioFire Blood Culture Identification 2 (BCID2) Panel, cleared 2020-03-18 for Biofire Diagnostics, LLC) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K193519 |
| Cleared Device Trade / Generic Name | BioFire Blood Culture Identification 2 (BCID2) Panel |
| FDA Applicant on Filing | Biofire Diagnostics, LLC |
| FDA 3-Letter Product Classification | Product Code PEN |
| FDA Substantial Equivalence Decision Date | 2020-03-18 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Biofire Diagnostics, LLC, compare peer devices under FDA Product Code PEN, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.